| Summary: | 碩士 === 國立雲林科技大學 === 企業管理系碩士班 === 93 === Recently, the older population has been growing and aging rapidly. People age 65 and older have chronic health problems, such as heart disease. Because of this aging trend, the cardiology and orthopedic markets will continue to account for the largest share of the medical device market. There will be increased competition betweem medical device companies, which will be producing more and more products that are directly competitive with each other. A company that develops an innovative new medical device wants to recoup the research cost and make a handsome profit. Patents prevent competitors from using the breakthrough technology without their approval; the patent holder can dominate the market, setting standards and prices. In medical device industry, companies use patent lawsuits as a way to harass their competitors. Patents have increasingly become a corporate weapon in the battle to bring lucrative products to market and block competitors.
The study constructs the patent portfolios of stent manufactories with RGR, RDGR, RPP and RPA four indicators, referring to the perspective of patent portfolios in the article “Patent portfolios for strategic R&D planning” (Ernst, 1998). We try to understand the technology capability and position of stent manufactories. Furthermore, to discuss the coo-petition relationship within the companies. This article also uses the patent portfolios for catching the technological trend of stent. And the result will provide decision-makers with the support they need in planning strategies.
|
|---|
